Arpa Garay
First SEC filing: June 29, 2022 · Latest: June 29, 2022
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 6, 2023 | MRNA | S | 564 | $78.34 | $44,184 | 3,690 Direct | -13.26% | Disposed | 142.5% (price as of 2026-10-02) |
| Dec. 5, 2023 | MRNA | M | 1,141 | · | · | 11,405 Direct | -9.09% | Disposed | (price as of 2026-10-02) |
| Dec. 5, 2023 | MRNA | M | 1,141 | · | · | 4,254 Direct | +36.65% | Acquired | (price as of 2026-10-02) |
| Sept. 6, 2023 | MRNA | S | 574 | $108.40 | $62,222 | 3,113 Direct | -15.57% | Disposed | 75.3% (price as of 2026-10-02) |
| Sept. 5, 2023 | MRNA | M | 1,140 | · | · | 12,546 Direct | -8.33% | Disposed | (price as of 2026-10-02) |
| Sept. 5, 2023 | MRNA | M | 1,140 | · | · | 3,687 Direct | +44.76% | Acquired | (price as of 2026-10-02) |
| June 6, 2023 | MRNA | S | 2,290 | $125.75 | $287,968 | 2,547 Direct | -47.34% | Disposed | 51.1% (price as of 2026-10-02) |
| June 5, 2023 | MRNA | M | 4,562 | · | · | 13,686 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| June 5, 2023 | MRNA | M | 4,562 | · | · | 4,837 Direct | +1658.91% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2023 | MRNA | A | 5,260 | · | · | 5,260 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2023 | MRNA | A | 20,040 | · | · | 20,040 Direct | · | Acquired | (price as of 2026-10-02) |
| May 4, 2022 | MRK | M | 907 | · | · | 1,819 Direct | -33.27% | Disposed | (price as of 2026-10-02) |
| May 4, 2022 | MRK | F | 259 | $87.10 | $22,559 | 2,109 Direct | -10.94% | Disposed | 65.7% (price as of 2026-10-02) |
| May 4, 2022 | MRK | M | 907 | $87.10 | $79,000 | 2,368 Direct | +62.08% | Acquired | 65.7% (price as of 2026-10-02) |
| May 3, 2022 | MRK | A | 21,359 | · | · | 21,359 Direct | · | Acquired | (price as of 2026-10-02) |
| May 3, 2022 | MRK | M | 773 | $87.65 | $67,753 | 1,682 Direct | +85.04% | Acquired | 64.6% (price as of 2026-10-02) |
| May 3, 2022 | MRK | F | 221 | $87.65 | $19,371 | 1,461 Direct | -13.14% | Disposed | 64.6% (price as of 2026-10-02) |
| May 3, 2022 | MRK | M | 773 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 1, 2022 | MRK | M | 866 | · | · | 866 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| May 1, 2022 | MRK | F | 247 | $88.69 | $21,906 | 909 Direct | -21.37% | Disposed | 62.7% (price as of 2026-10-02) |
| May 1, 2022 | MRK | M | 866 | $88.69 | $76,806 | 1,156 Direct | +298.62% | Acquired | 62.7% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 5, 2023 | MRNA | Restricted Stock Units | Common Stock | · | · | 1,141 | Disposed |
| Sept. 5, 2023 | MRNA | Restricted Stock Units | Common Stock | · | · | 1,140 | Disposed |
| June 5, 2023 | MRNA | Restricted Stock Units | Common Stock | · | · | 4,562 | Disposed |
| Feb. 28, 2023 | MRNA | Restricted Stock Units | Common Stock | $0.00 | · | 5,260 | Acquired |
| Feb. 28, 2023 | MRNA | Stock Option (Right to Buy) | Common Stock | $138.81 | Feb. 28, 2033 | 20,040 | Acquired |
| May 4, 2022 | MRK | Restricted Stock Unit | Common Stock | · | May 4, 2024 | 907 | Disposed |
| May 3, 2022 | MRK | Stock Option (Right to Buy) | Common Stock | $87.10 | May 2, 2032 | 21,359 | Acquired |
| May 3, 2022 | MRK | Restricted Stock Unit | Common Stock | · | May 3, 2022 | 773 | Disposed |
| May 1, 2022 | MRK | Restricted Stock Unit | Common Stock | · | May 1, 2023 | 866 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 29, 2022 | MRNA | Stock Option (Right to Buy) | 34,766 | Direct |
| June 29, 2022 | MRNA | Restricted Stock Units | 18,248 | Direct |
| March 10, 2022 | MRK | Common Stock | 290 | Direct |
| March 10, 2022 | MRK | Restricted Stock Unit | 773 | Direct |
| March 10, 2022 | MRK | Restricted Stock Unit | 1,732 | Direct |
| March 10, 2022 | MRK | Restricted Stock Unit | 1,828 | Direct |
| March 10, 2022 | MRK | Restricted Stock Unit | 2,726 | Direct |
| March 10, 2022 | MRK | Restricted Stock Unit | 13,087 | Direct |
| March 10, 2022 | MRK | Stock Option (Right to Buy) | 5,821 | Direct |
| March 10, 2022 | MRK | Stock Option (Right to Buy) | 13,543 | Direct |
| March 10, 2022 | MRK | Stock Option (Right to Buy) | 21,139 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $842,308 | · | · | · | $619,650 | · | $63,413 | $4,445,948 |
| 2022 | $458,462 | $1,500,000 | · | · | $508,932 | · | $203,303 | $7,676,152 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.